Crinetics Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Hey, good afternoon, everyone. My name is Jess Fye. I'm one of the senior biotech analysts at JPMorgan. And we're continuing the 2021 Healthcare Conference today with Crinetics. Things are a little different this year, so instead of going across the hall to the breakout room after the presentation, you can ask questions by using that blue, Ask A Question button on your screen. That'll submit them to me on the portal, and I can ask management during the Q&A session. So without any further delay, let me turn it over to Crinetics CEO, Scott Struthers.
Thanks, Jess. Thanks for the invite, and thanks to everybody listening. I'm here with Alan Krasner, our Chief Medical Officer; Gina Ford, our VP of Commercial Planning; and Marc Wilson, our CFO, who can help answer questions at the end of the talk portion.
I'll refer you to our forward-looking statements. Crinetics, as a reminder, is, in
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |